JAK2 and hepatocellular carcinoma: This finding aligns with the mechanism identified in hepatocellular carcinoma research, where phillyrin promotes ferroptosis by inhibiting the TOP2A-JAK2/STAT3 axis (29), suggesting that TOP2A may act as a conserved molecular node linking ferroptosis regulation and chemoresistance.